Anti-Mouse CD124/IL4RA Antibody (REGN1103） from ProteoGenix; catalogue ARO-A22683; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Mouse CD124/IL4RA Antibody (REGN1103) is a highly specific and reliable tool for targeting the IL4 receptor alpha (IL4RA) in mouse models. This antibody is produced by Regeneron, a leading biotechnology company known for its innovative and high-quality products.
IL4RA is a transmembrane protein that plays a key role in the immune system by regulating the differentiation and function of immune cells. It is a critical component of the IL4/IL13 signaling pathway, which is involved in various immune responses, including allergy and asthma. The Anti-Mouse CD124/IL4RA Antibody (REGN1103) binds to IL4RA and blocks its function, thereby modulating the immune response.
The Anti-Mouse CD124/IL4RA Antibody (REGN1103) is widely used in research studies to investigate the role of IL4RA in various diseases and conditions. It has been shown to be effective in inhibiting the development of allergic asthma in mouse models and has also been used to study the role of IL4RA in autoimmune diseases and cancer.
In a recent study, the Anti-Mouse CD124/IL4RA Antibody (REGN1103) was used to investigate the role of IL4RA in the development of atopic dermatitis, a common allergic skin condition. The results showed that blocking IL4RA with REGN1103 significantly reduced the severity of the disease in mouse models.
In another study, researchers used the Anti-Mouse CD124/IL4RA Antibody (REGN1103) to study the effect of IL4RA inhibition on tumor growth. The results showed that REGN1103 treatment significantly suppressed tumor growth in mouse models, suggesting a potential therapeutic application for cancer treatment.
With its high specificity and reliability, the Anti-Mouse CD124/IL4RA Antibody (REGN1103) is a valuable tool for researchers studying the role of IL4RA in various diseases and conditions.
In conclusion, the Anti-Mouse CD124/IL4RA Antibody (REGN1103) is a top-of-the-line product that offers precise and effective targeting of IL4RA in mouse models. Its wide range of applications and proven efficacy make it an essential tool for any research project involving IL4RA. Order now and take your research to the next level!
ProteoGenix catalogue number ARO-A22683. For research use only.
Target: CD124/IL4RA; Clonality: Monoclonal Antibody; Reactivity: Mouse; Applications: Neutralization, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Neutralization |
|---|---|---|---|---|---|---|---|---|---|
| Mouse |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
